Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China · Delayed Price · Currency is CNY 12.26
-0.11 (-0.89%)
Feb 4, 2026, 11:29 AM CST
Jiangsu Yahong Meditech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -362.17 | -384.06 | -400.43 | -246.55 | -234.95 | -247.27 |
Depreciation & Amortization | 30.12 | 30.12 | 19.27 | 11.55 | 7.4 | 1.36 |
Other Amortization | 4.84 | 4.84 | 5.21 | 4.48 | 4.29 | 1.84 |
Loss (Gain) From Sale of Assets | -0.05 | -0.05 | - | - | 0.02 | - |
Asset Writedown & Restructuring Costs | - | - | 0.03 | 1.84 | 1.19 | 0.2 |
Loss (Gain) From Sale of Investments | -24.46 | -24.46 | -25.39 | -57.58 | -16.37 | -3.67 |
Provision & Write-off of Bad Debts | 2.7 | 2.7 | 0.45 | 0.02 | 0.29 | 0.48 |
Other Operating Activities | 9.75 | 8.28 | 3.94 | -9.07 | 2.51 | 2.02 |
Change in Accounts Receivable | -89.33 | -89.33 | -45.9 | 13.5 | -20.8 | -14.52 |
Change in Inventory | -3.45 | -3.45 | 1.15 | -0.81 | -0.79 | -2.82 |
Change in Accounts Payable | 11.17 | 11.17 | 27.22 | 33.75 | 24.96 | 8.47 |
Change in Other Net Operating Assets | 20.1 | 20.1 | 17.29 | 6.95 | 60.74 | 127.95 |
Operating Cash Flow | -401.59 | -424.95 | -398.19 | -241.96 | -171.52 | -125.95 |
Capital Expenditures | -14.75 | -5.79 | -101.63 | -26.61 | -42.4 | -14.3 |
Sale of Property, Plant & Equipment | 0.02 | 0.07 | - | - | 0 | - |
Investment in Securities | 307.93 | 804.84 | -274.89 | -1,291 | 165.73 | -515.46 |
Other Investing Activities | 0 | -1.87 | 9.72 | - | - | 7.8 |
Investing Cash Flow | 293.2 | 797.25 | -366.8 | -1,318 | 123.33 | -521.95 |
Short-Term Debt Issued | - | 66.2 | 73.4 | - | - | - |
Total Debt Issued | 260.99 | 66.2 | 73.4 | - | - | - |
Short-Term Debt Repaid | - | -73.4 | - | - | - | - |
Long-Term Debt Repaid | - | -17.26 | -11.36 | -8.99 | -4.52 | -15.78 |
Total Debt Repaid | -83.46 | -90.66 | -11.36 | -8.99 | -4.52 | -15.78 |
Net Debt Issued (Repaid) | 177.53 | -24.46 | 62.04 | -8.99 | -4.52 | -15.78 |
Issuance of Common Stock | 8.07 | - | - | - | 2,396 | 897.06 |
Repurchase of Common Stock | -50.06 | -50.06 | - | - | - | - |
Common Dividends Paid | -7.41 | -2.49 | -0.41 | - | - | -0.36 |
Other Financing Activities | 45.31 | - | 0.39 | -22.05 | -8.03 | -0.1 |
Financing Cash Flow | 173.43 | -77.01 | 62.01 | -31.05 | 2,384 | 880.82 |
Foreign Exchange Rate Adjustments | -2.11 | -1.95 | 0.76 | 7.35 | -2 | -1.8 |
Net Cash Flow | 62.94 | 293.34 | -702.22 | -1,584 | 2,334 | 231.11 |
Free Cash Flow | -416.34 | -430.74 | -499.82 | -268.57 | -213.92 | -140.25 |
Free Cash Flow Margin | -149.22% | -213.70% | -3634.18% | -1029206.22% | -4676788.98% | - |
Free Cash Flow Per Share | -0.74 | -0.73 | -0.84 | -0.47 | -0.46 | -0.31 |
Cash Income Tax Paid | 23.11 | 13.75 | 1.94 | -22.57 | -2.7 | 0.19 |
Levered Free Cash Flow | -285.69 | -271.45 | -334.62 | -204.07 | -106.45 | -44.07 |
Unlevered Free Cash Flow | -278.72 | -267.23 | -332.76 | -203.59 | -106.15 | -44.04 |
Change in Working Capital | -62.33 | -62.33 | -1.26 | 53.35 | 64.11 | 119.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.